According to filings with the U.S. Securities and Exchange Commission, Precision Neuroscience is raising $42,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Michael Mager played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Precision Neuroscience
Our mission at Precision Neuroscience is to develop and commercialize brain-computer interfaces (BCI). We are pursuing minimally invasive approaches to BCI to address major unmet clinical needs. We are well-capitalized and have an IP portfolio that has been built over nearly 10 years. Brain-computer interfaces represent a new frontier in medicine and computing. We seek to establish Precision Neuroscience as one of the leading companies in this space globally. Our core objective is to deliver life-changing technology to millions of patients worldwide, and in doing so to transform the ways we interact with machines, one another, and our world.

To learn more about Precision Neuroscience, visit http://precisionneuro.io/

Contact:
Michael Mager, Chief Executive Officer
646-771-5881
https://www.linkedin.com/in/michael-mager-b458437/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.